Literature DB >> 17574791

Co-occurring disorders in substance abuse treatment: issues and prospects.

Patrick M Flynn1, Barry S Brown.   

Abstract

This article explores the epidemiology of co-occurring disorders (CODs) with an emphasis on the implications of study findings for the functioning and potential of substance abuse treatment. Severity of disorder is discussed as an issue that may have particular significance for the selection of specialized as opposed to traditional substance abuse treatment forms. Exploration is made, as well, of the resources currently available to substance abuse treatment, especially the human resources available, and the implications of resource availability for undertaking initiatives specific to COD. Findings from standard and enhanced treatment for comorbid individuals are examined in an effort to clarify areas of need for specialized and typical treatment personnel. Issues are raised for consideration by the clinical research and treatment provider communities in terms of assessment and diagnosis, manpower and training, and response to the challenge of relapse in this population.

Entities:  

Mesh:

Year:  2007        PMID: 17574791      PMCID: PMC2200799          DOI: 10.1016/j.jsat.2006.11.013

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  79 in total

1.  A national survey of care for persons with co-occurring mental and substance use disorders.

Authors:  K E Watkins; A Burnam; F Y Kung; S Paddock
Journal:  Psychiatr Serv       Date:  2001-08       Impact factor: 3.084

2.  Dual diagnosis: 15 years of progress.

Authors:  R E Drake; M A Wallach
Journal:  Psychiatr Serv       Date:  2000-09       Impact factor: 3.084

Review 3.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

Authors:  A T McLellan; D C Lewis; C P O'Brien; H D Kleber
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

4.  Matching clients' needs with drug treatment services.

Authors:  Y I Hser; M L Polinsky; M Maglione; M D Anglin
Journal:  J Subst Abuse Treat       Date:  1999-06

5.  Integrated treatment of comorbid depression and substance use disorders.

Authors:  D A Charney; A M Paraherakis; K J Gill
Journal:  J Clin Psychiatry       Date:  2001-09       Impact factor: 4.384

6.  Depressive symptomatology and early attrition from intensive outpatient substance use treatment.

Authors:  Geoffrey M Curran; JoAnn E Kirchner; Mark Worley; Craig Rookey; Brenda M Booth
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

7.  Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs.

Authors:  K M Broome; P M Flynn; D D Simpson
Journal:  Health Serv Res       Date:  1999-08       Impact factor: 3.402

8.  Comorbidity between patterns of substance use dependence and psychiatric syndromes.

Authors:  D B Kandel; F Y Huang; M Davies
Journal:  Drug Alcohol Depend       Date:  2001-10-01       Impact factor: 4.492

9.  Current Status of Professional Training in the Addictions.

Authors:  Daniel S. Keller; Helen Dermatis
Journal:  Subst Abus       Date:  1999-09       Impact factor: 3.716

Review 10.  Illness management and recovery: a review of the research.

Authors:  Kim T Mueser; Patrick W Corrigan; David W Hilton; Beth Tanzman; Annette Schaub; Susan Gingerich; Susan M Essock; Nick Tarrier; Bodie Morey; Suzanne Vogel-Scibilia; Marvin I Herz
Journal:  Psychiatr Serv       Date:  2002-10       Impact factor: 3.084

View more
  44 in total

1.  Effect of comorbid alcohol and drug use disorders on premature death among unipolar and bipolar disorder decedents in the United States, 1999 to 2006.

Authors:  Young-Hee Yoon; Chiung M Chen; Hsiao-Ye Yi; Howard B Moss
Journal:  Compr Psychiatry       Date:  2010-12-13       Impact factor: 3.735

2.  Treating depression and substance use: a randomized controlled trial.

Authors:  Sarah B Hunter; Katherine E Watkins; Kimberly A Hepner; Susan M Paddock; Brett A Ewing; Karen C Osilla; Suzanne Perry
Journal:  J Subst Abuse Treat       Date:  2012-02-01

3.  Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders.

Authors:  Ramin Mojtabai; Lian-Yu Chen; Christopher N Kaufmann; Rosa M Crum
Journal:  J Subst Abuse Treat       Date:  2013-08-29

4.  Responding to the challenge of co-occurring disorders: suggestions for future research.

Authors:  Stanley Sacks; Redonna Chandler; Junius Gonzales
Journal:  J Subst Abuse Treat       Date:  2007-06-15

5.  Does group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment clients?

Authors:  Susan M Paddock; Sarah B Hunter; Thomas J Leininger
Journal:  J Subst Abuse Treat       Date:  2014-03-01

6.  Services and supports for individuals with co-occurring disorders and long-term homelessness.

Authors:  Susan Foster; Charlene LeFauve; Marilyn Kresky-Wolff; Lawrence D Rickards
Journal:  J Behav Health Serv Res       Date:  2009-09-19       Impact factor: 1.505

7.  Help-seeking behaviors in a community sample of young adults with substance use disorders.

Authors:  Mathew D Gayman; Gary S Cuddeback; Joseph P Morrissey
Journal:  J Behav Health Serv Res       Date:  2011-10       Impact factor: 1.505

8.  Classifying substance use disorder treatment facilities with co-located mental health services: A latent class analysis approach.

Authors:  Pia M Mauro; C Debra Furr-Holden; Eric C Strain; Rosa M Crum; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2016-04-07       Impact factor: 4.492

9.  Comorbid depression and substance abuse among safety-net clients in Los Angeles: a community participatory study.

Authors:  Evelyn T Chang; Kenneth B Wells; James Gilmore; Lingqi Tang; Anna U Morgan; Starr Sanders; Bowen Chung
Journal:  Psychiatr Serv       Date:  2014-12-01       Impact factor: 3.084

10.  Substance Use and Mental Health Outcomes for Comorbid Patients in Psychiatric Day Treatment.

Authors:  Stephen Magura; Andrew Rosenblum; Thomas Betzler
Journal:  Subst Abuse       Date:  2009-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.